Dr. Michael Sidler is an Observer of the Board at TOLREMO. In 2007, he co-founded Redalpine Venture Partners AG in Zurich and acts as General Partner for the currently existing Redalpine Capital Funds I – IV. Before Redalpine, Michael was responsible for corporate investments and M&A at Prionics AG, a Biotech company in Schlieren, Switzerland, where under his guidance several acquisitions were completed. From 1998 to 2003, Michael was with The Boston Consulting Group in Zurich and Toronto as a Consultant and Project Leader in several different industries and roles. He is a member of several organizations, juries and boards for the support of innovation, startups, and venture capital (Venturekick, Startup Finance, SECA).
Michael holds a PhD in Life Sciences from the University of Zurich.